Bodal expects Saykha plant profit contribution this quarter
Key highlights
- Bodal expects the Saykha benzene downstream plant to contribute to net profit in the current quarter.
- The Saykha plant recorded about Rs 30 crore of EBITDA losses in each of the preceding two years.
- Bodal's consolidated H1 FY27 revenue rose 67% year on year to Rs 1,599 crore.
- Bodal's consolidated H1 FY27 EBITDA increased 114% year on year to Rs 203 crore.
powered by IRIS

Bodal Chemicals Limited expects its Saykha benzene downstream plant to contribute to net profit in the current quarter, following approximately Rs 30 crore of earnings before interest, tax, depreciation and amortisation (EBITDA) losses in each of the preceding two years. Management linked the expected change to higher utilisation, improved production and better price realisations.
Know Bodal Chemicals inside out
Results, valuation, peers and who's buying, in one view.
Why does Bodal expect the Saykha plant to contribute to profit?
Bodal expects the Saykha plant to contribute to net profit this quarter because utilisation reached a satisfactory level in H1 FY27 and improved further in the current quarter, alongside stronger price realisations. Management said the benzene downstream operation had started contributing to top line in H1 FY27 and that better volumes and realisations should lead to a meaningful bottom-line contribution quarter on quarter.
The plant had recorded EBITDA losses of about Rs 30 crore in each of the preceding two years because low utilisation could not absorb its significant overheads, according to management. Bodal said stabilisation took longer than expected due to the integration of several foreign technologies, while the wider dyes and dye-intermediates market faced weaker demand conditions from FY23 through FY26.
How does the Saykha turnaround fit into Bodal's H1 FY27 results?
The Saykha turnaround is one element of Bodal's broader earnings improvement, rather than a separately quantified source of H1 FY27 profit. Consolidated revenue rose 67% year on year to Rs 1,599 crore in H1 FY27 from Rs 959 crore in H1 FY26, while consolidated net profit increased to Rs 112 crore from Rs 16 crore.
Bodal reported Q2 FY27 consolidated revenue of Rs 884 crore, up 77% year on year, and EBITDA of Rs 128 crore, up 197%. The Q2 EBITDA margin was 14.4%, and consolidated net profit was Rs 81 crore, up 1,259% year on year. Management attributed the half-year performance to improved realisations and volumes across divisions, with Saykha expected to move from an earnings drag to a contributor.
What financial disclosure has Bodal made for benzene derivatives?
Bodal has not disclosed separate revenue, EBITDA, profit or utilisation figures for Saykha benzene downstream products in the call. It said the division began contributing to top line in H1 FY27, but described the expected bottom-line contribution qualitatively rather than providing a target for the current quarter.
The disclosed segment figures show that dye intermediates generated Rs 562 crore of H1 FY27 revenue, followed by dyestuff at Rs 361 crore, basic chemicals at Rs 183 crore and chlor-alkali at Rs 178 crore. In Q2 FY27, these divisions reported revenue of Rs 345 crore, Rs 212 crore, Rs 99 crore and Rs 91 crore respectively. Benzene derivatives were not separately reported in either period.
That disclosure gap means the call does not allow readers to calculate how much of Bodal's Rs 203 crore H1 FY27 consolidated EBITDA came from Saykha. It also prevents a direct comparison between the plant's earlier Rs 30 crore EBITDA losses and its expected current-quarter profit contribution. The reported evidence is operational: higher utilisation, improved production and better price realisations.
Got a follow-up? Ask IRIS
What other businesses supported Bodal's earnings growth?
Dye intermediates were the largest disclosed H1 FY27 revenue division at Rs 562 crore, with revenue up 68% year on year. Q2 FY27 dye-intermediates revenue was Rs 345 crore, up 88%. Management said better margins in key dye intermediates and the pass-through of higher raw-material costs supported the group's H1 FY27 EBITDA growth of 114% to Rs 203 crore.
Dyestuff revenue increased 42% in H1 FY27, while Q2 FY27 dyestuff revenue grew 60% to Rs 212 crore. Bodal said about 40% of its dye-intermediates production is consumed captively in dyestuff, creating a cost advantage. Management also said dyestuff utilisation had averaged about 65% to 70% over recent years, leaving scope to convert intermediates into dyestuff when market conditions support it.
Basic-chemicals revenue rose 136% in H1 FY27 and 199% in Q2 FY27 to Rs 99 crore, mainly because sulphur prices increased. Chlor-alkali revenue grew 6% in H1 FY27 to Rs 178 crore and 8% in Q2 FY27 to Rs 91 crore, helped by better realisations. These differing segment trends show that the H1 improvement was spread across the portfolio rather than solely linked to Saykha.
What could determine whether Saykha's contribution continues?
Continued production, utilisation and price realisations at Saykha will determine whether the expected profit contribution persists, because management gave no unit-level financial target. Bodal said international challenges had not been fully resolved, although the industry appeared to have adapted to disruptions since the start of FY27. It also expects better production to support its trichloroisocyanuric acid, or TCCA, business in the coming quarter.
Management's market visibility for H acid, a dye intermediate, extended only to January at the time of the November 3, 2026 call. It said commitments existed for supply to China through January, while visibility for February and March should emerge around December because the business generally operates one or two months ahead. H acid had reached about Rs 1,800 before correcting to about Rs 1,600, a level management said was being passed through into dyestuff.
Bodal also said higher H1 FY27 turnover increased inventory and receivables, though management said receivable days had not risen materially. It expects working-capital requirements to normalise when turnover stabilises for one or two quarters. Management said future cash generation is intended primarily for debt repayment, while it may also assess growth projects at its Bharuch and Punjab sites and potential acquisitions.
Conclusion
Bodal's stated change at Saykha is from approximately Rs 30 crore of EBITDA losses in each of the preceding two years to an expected net-profit contribution in the current quarter. The operational basis is improved utilisation, production and realisations, while the group backdrop includes Rs 1,599 crore of H1 FY27 consolidated revenue and Rs 203 crore of EBITDA.
The next results will show whether Bodal provides a separate financial measure for benzene derivatives and whether Saykha's higher operating levels continue. Management's disclosed items to watch are H acid order visibility beyond January, TCCA production progress, turnover stabilisation over one or two quarters, debt repayment plans and potential expansion or acquisition decisions.


